Influence of Specific Collagen Peptides on Recovery After Exercise Induced Muscle Damage
Launched by UNIVERSITY OF VIENNA · Jan 28, 2022
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • No subjective symptoms during physical exertion
- • Stable weight and dietary behaviour
- • Body Mass Index (BMI) between 18.5 and 24.9
- • No extensive strength/endurance sports so far (less than 3 h/week)
- • No complaints during strenuous physical activity
- Exclusion Criteria:
- • Circumstances that impair/prevent sporting activity (e.g. chronic heart disease, arrhythmia, heart valve disease, arthritis etc.)
- • Intolerance/aversion to animal protein
- • Arterial hypertension (high blood pressure) (syst \> 200 mmHg and/or diast \> 105 mmHg) at rest
- • Presence of insulin-dependent diabetes mellitus
- • Liver and/or kidney disease that precludes a high protein load
- • Collagen supplementation or regular intake of other dietary supplements in the last 6 months.
About University Of Vienna
The University of Vienna, a leading research institution in Europe, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research methodologies, the university aims to enhance patient care and public health outcomes. Its clinical trial programs are designed to address critical healthcare challenges by evaluating new therapies and interventions, contributing to the evidence-based practice of medicine. Through rigorous ethical standards and a commitment to scientific excellence, the University of Vienna plays a pivotal role in shaping the future of healthcare research and education.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Daniel Koenig, Prof. Dr.
Principal Investigator
University of Vienna, Institute of Sport Science
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials